4.6 Article

Modulation of LXR-α and the effector genes by Ascorbic acid and Statins in psoriatic keratinocytes

期刊

MOLECULAR AND CELLULAR BIOCHEMISTRY
卷 397, 期 1-2, 页码 1-6

出版社

SPRINGER
DOI: 10.1007/s11010-014-2063-x

关键词

LXR-alpha; SREBP-1C; Psoriasis; Statins; Ascorbic acid

向作者/读者索取更多资源

Recent studies have revealed critical roles that nuclear receptors like LXR-alpha (Liver X Receptor- alpha) plays as a class of post-transcriptional gene regulator in skin development and diseases. Keeping in view the fact that LXR-alpha plays crucial role in keratinocyte proliferation and differentiation, it becomes imperative to dissect the pathways and role of LXR-alpha genomics in the pathogenesis of psoriasis with ultimate aim to explore novel preventive/therapeutic strategies as treatment options. To explore the effects of agonists and activators of LXR-alpha on its own gene expression and the putative targets in psoriatic keratinocytes. Identification of promoter sequences for (vitamin D receptor) VDR and Catalase were done using in silico analysis followed by beta-galactosidase (beta-gal) reporter plasmid assay in keratinocytes from clinically heathy subjects. Determination of relative levels of LXR-alpha,VDR and catalase in control versus treated cells upon activation of LXR-alpha with Atorvastatin + 22R hydroxycholestrol and Ascorbic acid + 22R hydroxycholestrol was done by PCR and Cell Proliferation Assay. The cells transfected with the reporter plasmid element for VDR and catalase showed more than 5 and 4 fold increase respectively in the beta-gal activity compared to the control. An increase of 55 % in LXR-alpha gene expression at RNA level was observed in Atorvastatin + 22-R hydroxycholestrol compared to 24 % in Ascorbic acid + 22-ROH cholesterol. The expression of the VDR and Catalase was significantly increased in both treated keratinocytes compared to its normal counterpart.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Dermatology

Aberrant ETS-1 signalling impedes the expression of cell adhesion molecules and matrix metalloproteinases in non-segmental vitiligo

Niharika Srivastava, Anuradha Bishnoi, Sakshi Mehta, Seema Rani, Ravinder Kumar, Supriya Bhardwaj, Muthu Sendhil Kumaran, Vinay Keshavamurthy, Sarika Gupta, Davinder Parsad

EXPERIMENTAL DERMATOLOGY (2020)

Review Dermatology

Emerging role of dermal compartment in skin pigmentation: comprehensive review

R. Kapoor, S. K. Dhatwalia, R. Kumar, S. Rani, D. Parsad

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)

Article Dermatology

Oral mycophenolate mofetil as a stabilizing treatment for progressive non-segmental vitiligo: results from a prospective, randomized, investigator-blinded pilot study

Anuradha Bishnoi, Keshavamurthy Vinay, Muthu Sendhil Kumaran, Davinder Parsad

Summary: The study demonstrates that both oral mycophenolate mofetil and dexamethasone oral mini-pulse effectively stabilize active vitiligo. Both treatments showed significant improvements in disease activity and new lesion numbers, but patients using mycophenolate mofetil had slightly higher Vitiligo Area Scoring Index at 270 days compared to those using dexamethasone oral mini-pulse.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2021)

Article Dermatology

Chemical induced pathognomonic features observed in human vitiligo are mediated through miR-2909 RNomics pathway

Hitaishi Kaushik, Deepak Kaul, Muthu Sendhil Kumaran, Davinder Parsad

JOURNAL OF DERMATOLOGICAL SCIENCE (2020)

Article Dermatology

A prospective, randomized clinical study to compare the efficacy of recipient site preparation using dermabrasion, cryoblister, and dermaroller in autologous noncultured epidermal cell suspension in stable vitiligo

Kiruthika Subburaj, Vishal Thakur, Muthu Sendhil Kumaran, Keshavamurthy Vinay, Niharika Srivastava, Davinder Parsad

Summary: Dermabrasion and cryoblister techniques have comparable efficacy in treating stable vitiligo, with dermabrasion showing superiority in terms of speed and color match. However, dermaroller has poorer repigmentation outcomes compared to dermabrasion and cryoblister in this study.

DERMATOLOGIC THERAPY (2021)

Article Oncology

Immune-modulatory effects of lenalidomide inhibited the progression of lesions in a vitiligo mouse model

Naveed Pervaiz, Harjot Kaur, Davinder Parsad, Ravinder Kumar

Summary: The study investigated the effects of lenalidomide on vitiligo mouse models, showing that lenalidomide could suppress the development of vitiligo lesions by reducing levels of pro-inflammatory cytokines and increasing levels of anti-inflammatory cytokines, modulating the immune response towards an anti-inflammatory profile.

PIGMENT CELL & MELANOMA RESEARCH (2021)

Review Oncology

Vitiligo: Translational research and effective therapeutic strategies

Vishal Thakur, Anuradha Bishnoi, Keshavamurthy Vinay, Sendhil M. Kumaran, Davinder Parsad

Summary: This is an exciting phase of vitiligo research as understanding of vitiligo pathogenesis has led to successful treatment. Vitiligo originates from autoimmunity with contributions from factors like oxidative stress and melanocyte defects. Treatment aims to rescue melanocytes to arrest depigmentation and replenish them for successful repigmentation, while also focusing on maintaining stability to prevent relapse, especially in non-segmental vitiligo.

PIGMENT CELL & MELANOMA RESEARCH (2021)

Letter Dermatology

Dermatoscopic features of dermatoses of acquired dermal hyperpigmentation: Is there a difference?

Hitaishi Mehta, Anuradha Bishnoi, Keshavamurthy Vinay, Muthu Sendhil Kumaran, Davinder Parsad

INTERNATIONAL JOURNAL OF DERMATOLOGY (2022)

Article Dermatology

Catecholamines' accumulation and their disturbed metabolism at perilesional site: a possible cause of vitiligo progression

Sushma Tanwar, Vishal Thakur, Alka Bhatia, Davinder Parsad

Summary: This study evaluated the levels of catecholamines and gene expression changes in active vitiligo patients. The results showed elevated levels of catecholamines in the perilesional skin of patients, indicating oxidative stress, inflammation, and immune response.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2023)

Review Dermatology

Mitochondria-Melanocyte cellular interactions: An emerging mechanism of vitiligo pathogenesis

Hitaishi Kaushik, Vinod Kumar, Davinder Parsad

Summary: Mitochondria plays a role in melanocyte function and can be associated with certain diseases, such as Duchenne muscular dystrophy and vitiligo. The exact mechanism of melanocyte destruction in vitiligo is still unknown, but studies suggest that mitochondrial function, inter- and intra-organellar communications, and melanosome association may be involved. Understanding the role of mitochondria in vitiligo could lead to new treatments for the disease.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Article Dermatology

Reliability and agreement testing of a new automated measurement method to determine facial vitiligo extent using standardized ultraviolet images and a dedicated algorithm

Quentin Marin Dit Bertoud, Clemence Bertold, Khaled Ezzedine, Amit G. Pandya, Marie Cherel, Alejandro Castillo Martinez, Marie-Anne Seguy, Marwa Abdallah, Jung Min Bae, Markus Boehm, Davinder Parsad, David Rosmarin, Albert Wolkerstorfer, Philippe Bahadoran, Manon Blaise, Pierre-Michel Dugourd, Valerie Philippo, Jean-Michel Delaval, Thierry Passeron

Summary: The study developed an algorithm called Vitil-IA to assess depigmentation on standardized facial ultraviolet (UV) pictures in vitiligo patients. The algorithm showed excellent reproducibility and high agreement with the assessment by raters. The study also revealed the limitations of the F-VASI score when performed by non-experts for homogeneous vitiligo depigmentation and in the case of heterogeneous depigmentation.

BRITISH JOURNAL OF DERMATOLOGY (2023)

Review Dermatology

Acquired dermal macular hyperpigmentation: an overview of the recent updates

Shikha Shah, Narayanan Baskaran, Keshavamurthy Vinay, Anuradha Bishnoi, Davinder Parsad, Muthu S. Kumaran

Summary: Acquired dermal macular hyperpigmentation (ADMH) is an umbrella concept that unifies various acquired pigmentary disorders characterized by dermal pigmentation. The treatment of ADMH remains challenging.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2023)

Article Dermatology

A randomized prospective study to assess the role of topical tacrolimus as preventive therapy in unstable acral vitiligo

Deepak Kumar, Vishal Thakur, Kiruthika Subburaj, Anuradha Bishnoi, Keshavamurthy Vinay, Muthu Sendhil Kumaran, Davinder Parsad

Summary: This study found that the application of 0.1% tacrolimus ointment can effectively prevent the appearance of new lesions and promote repigmentation in unstable acral vitiligo. Moreover, using the ointment on both affected and unaffected skin yields better results.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Article Dermatology

Immune modulatory effects of lenalidomide on the cultured peripheral blood mononuclear cells from vitiligo patients

Naveed Pervaiz, Harjot Kaur, Davinder Parsad, Ravinder Kumar

DERMATOLOGIC THERAPY (2020)

暂无数据